GE HealthCare Technologies profit margin GEHC
Gross, operating and net profit as a share of revenue over the last twelve months, from 2022.
- Net margin, 12 months
- 9.3%
- Operating margin, 12 months
- 12.9%
- Net margin on a year earlier
- −1.9 pts
- Peer median
- 14.2%
Over the twelve months to Jun 30, 2026, GE HealthCare Technologies kept 9.3% of its revenue as net profit, with an operating margin of 12.9% and a gross margin of 39.5%.
The median for 9 medical device stocks of a similar size is 14.2%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2025 | 10.1% | 13.4% | 40.0% |
| FY2024 | 10.1% | 13.3% | 41.7% |
| FY2023 | 8.0% | 12.5% | 40.5% |
| FY2022 | 10.4% | 13.8% | 39.1% |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q2 FY26 | 9.3% | −1.9 pts | 12.9% | |
| Q1 FY26 | 9.1% | −1.9 pts | 12.6% | |
| Q4 FY25 | 10.1% | −0.0 pts | 13.4% | |
| Q3 FY25 | 11.0% | +2.4 pts | 13.5% | |
| Q2 FY25 | 11.2% | +3.1 pts | 13.8% | |
| Q1 FY25 | 11.0% | +3.0 pts | 13.7% | |
| Q4 FY24 | 10.1% | +2.1 pts | 13.3% | |
| Q3 FY24 | 8.6% | −0.3 pts | 12.8% | |
| Q2 FY24 | 8.1% | −1.5 pts | 12.6% | |
| Q1 FY24 | 8.1% | −2.1 pts | 12.4% | |
| Q4 FY23 | 8.0% | −2.4 pts | 12.5% | |
| Q3 FY23 | 8.9% | n/a | 13.1% |
Against its peers
Companies in Medical - Devices nearest GE HealthCare Technologies' size, closest first, today.
| Company | Profit margin |
|---|---|
| GEHCGE HealthCare Technologies | 9.3% |
| DXCMDexCom | 20.1% |
| EWEdwards Lifesciences | 15.4% |
| ZBHZimmer Biomet | 9.5% |
| BSXBoston Scientific | 17.5% |
| SYKStryker | 14.4% |
| MDTMedtronic | 13.9% |
| ABTAbbott Laboratories | n/m |
| LIVNLivaNova | 12.8% |
| ITGRInteger | 7.0% |
| Peer median | 14.2% |
Where GE HealthCare Technologies ranks
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on GE HealthCare Technologies
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.